| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Short Communications |
From the Institute of Clinical Pathology*
and Division
of Immunology, Allergy, and Infectious
Diseases,
Department of Dermatology,
University of Vienna Medical School, Vienna, Austria
Prion diseases are transmissible spongiform encephalopathies
of humans and animals characterized by the accumulation of a
proteinase-resistant isoform of the cellular prion-related protein
(PrPc) within the central nervous system. In the present
report we demonstrate for the first time the presence of
PrPc on squamous epithelia of normal and diseased human
skin and show that inflammatory cytokines regulate PrPc
expression in cultured human keratinocytes (KCs). By
immunohistochemistry, only little expression of
PrPc, which was mainly confined to KCs, was
detected in normal skin. In contrast, in inflammatory skin
diseases including psoriasis and contact dermatitis,
PrPc was strongly present on both KCs and infiltrating
mononuclear cells. Strong PrPc expression was also observed
in squamous cell carcinomas and viral warts whereas basal cell
carcinomas were mostly negative. In mucous membranes of the upper
digestive tract and the genital region, distinct
PrPc expression by basal squamous epithelial cells was a
constant feature. In tissue culture, primary KCs constitutively
expressed PrPc mRNA and protein. Exposure of these cells to
transforming growth factor (TGF)-
or interferon (IFN)-
led to an
increase of PrPc protein expression. The presence of
PrPc on epithelial cells of skin and mucous membranes
suggests that these cells represent possible first targets for
peripheral infection with prions.
This article has been cited by other articles:
![]() |
R. Linden, V. R. Martins, M. A. M. Prado, M. Cammarota, I. Izquierdo, and R. R. Brentani Physiology of the Prion Protein Physiol Rev, April 1, 2008; 88(2): 673 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Pan, L. Zhao, J. Liang, J. Liu, Y. Shi, N. Liu, G. Zhang, H. Jin, J. Gao, H. Xie, et al. Cellular prion protein promotes invasion and metastasis of gastric cancer FASEB J, September 1, 2006; 20(11): 1886 - 1888. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. F. McLennan, P. M. Brennan, A. McNeill, I. Davies, A. Fotheringham, K. A. Rennison, D. Ritchie, F. Brannan, M. W. Head, J. W. Ironside, et al. Prion Protein Accumulation and Neuroprotection in Hypoxic Brain Damage Am. J. Pathol., July 1, 2004; 165(1): 227 - 235. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Budka Neuropathology of prion diseases Br. Med. Bull., June 1, 2003; 66(1): 121 - 130. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Moudjou, Y. Frobert, J. Grassi, and C. La Bonnardiere Cellular prion protein status in sheep: tissue-specific biochemical signatures J. Gen. Virol., August 1, 2001; 82(8): 2017 - 2024. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lemaire-Vieille, T. Schulze, V. Podevin-Dimster, J. Follet, Y. Bailly, F. Blanquet-Grossard, J.-P. Decavel, E. Heinen, and J.-Y. Cesbron Epithelial and endothelial expression of the green fluorescent protein reporter gene under the control of bovine prion protein (PrP) gene regulatory sequences in transgenic mice PNAS, May 9, 2000; 97(10): 5422 - 5427. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |